Abstract
Endoscopic therapy is increasingly used to treat high-grade dysplasia and/or early mucosal adenocarcinoma in patients with Barrett's esophagus. However, no randomized controlled trials have directly compared the efficacy of endoscopic therapy and traditional surgical approaches. This commentary discusses the findings of a retrospective, population-based study by Das et al. that demonstrates the effectiveness of endoscopic resection and/or endoscopic ablation in the treatment of early esophageal cancer. This study used data from the Surveillance Epidemiology and End Results database of the National Cancer Institute to compare cancer-free survival in patients with early esophageal cancer who were either treated with endoscopic therapy (n = 99) or surgical resection (n = 643). Analysis using a Cox proportional hazards model did not reveal a difference in esophageal cancer-specific mortality between the two groups. These results, therefore, support the use of endoscopic therapy in the treatment of early-stage esophageal cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Buttar NS et al. (2001) Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 54: 682–688
Overholt BF et al. (2005) Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62: 488–498
Overholt BF et al. (2007) Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc 66: 460–468
Ell C et al. (2007) Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 65: 3–10
Shaheen NJ et al. (2008) A randomized multicenter, sham-controlled trial of radiofrequency ablation (RFA) for subjects with Barrett's esophagus (BE) containing dysplasia: Interim results of the AIM dysplasia trial [abstract]. Gastroenterology 134: A37
Das A et al. (2008) A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 103: 1340–1345
Prasad GA et al. (2007) Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 132: 1226–1233
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Singh, S., Sharma, P. How effective is endoscopic therapy in the treatment of patients with early esophageal cancer?. Nat Rev Gastroenterol Hepatol 6, 70–71 (2009). https://doi.org/10.1038/ncpgasthep1330
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep1330
This article is cited by
-
Management controversies in Barrett’s oesophagus
Journal of Gastroenterology (2014)